NR1H4 and Cirrhosis: BAs exert both direct antimicrobial properties and indirect negative selective pressure on intestinal bacteria through FXR activation in the small intestine, which induces antimicrobial peptide synthesis, and FXR agonists reduce BT through the portal pathway to the liver in cirrhosis [92,95].